As of Aug 03
| -0.03 / -0.60%|
The 4 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 13.50, with a high estimate of 17.00 and a low estimate of 12.00. The median estimate represents a +172.73% increase from the last price of 4.95.
The current consensus among 4 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.